diethylnitrosamine has been researched along with bicyclol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, GT; Strada, SJ; Wu, RS; Zhu, B | 1 |
| Liu, G; Sun, H; Wei, H; Yu, L | 1 |
2 other study(ies) available for diethylnitrosamine and bicyclol
| Article | Year |
|---|---|
Chemoprevention of bicyclol against hepatic preneoplastic lesions.
Topics: Animals; Antineoplastic Agents; Biphenyl Compounds; Cell Transformation, Neoplastic; Chemoprevention; Diethylnitrosamine; Disease Models, Animal; Gene Expression Regulation; Genes, myc; Genes, ras; Liver Neoplasms; Male; Precancerous Conditions; Rats; Rats, Wistar; RNA, Messenger | 2006 |
A novel antihepatitis drug, bicyclol, prevents liver carcinogenesis in diethylnitrosamine-initiated and phenobarbital-promoted mice tumor model.
Topics: Analysis of Variance; Animals; Antineoplastic Agents; Biphenyl Compounds; Body Weight; Cell Line; Diethylnitrosamine; Histocytochemistry; Liver Function Tests; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred ICR; Phenobarbital; Proliferating Cell Nuclear Antigen | 2012 |